The University of Texas MD Anderson Cancer Center today honored Tiffany Richards, Ph.D., A.P.R.N., A.N.P.-B.C., A.O.C.N.P., with the 2024 Brown Foundation Award for Excellence in Oncology Nursing. As the institution’s highest nursing honor, this award celebrates outstanding achievements in oncology nursing, including exceptional patient care and a commitment to excellence in clinical practice.
The FDA has granted regenerative medicine advanced therapy to ALLO-316 in CD70-positive advanced or metastatic renal cell carcinoma.
The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of zenocutuzumab for NRG1-positive lung and pancreatic cancer.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Becker’s is thrilled to honor healthcare CNOs. Chief nursing officers are responsible for tackling nurse staffing shortages, managing nursing budgets and more.
round Data: Increasingly, ctDNA is being used for clinical decision-making in a variety of solid malignancies. However, the detection and prognostic value of KRAS ctDNA…
Susan L. Slager, PhD, discussed the etiology and inherited genetic factors that are associated with the risk of chronic lymphocytic leukemia.
For the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA -mutated (g BRCA m or s BRCA m) advanced…
A next-generation sequencing–based molecular assay using urine holds promise for improving the clinical staging of non-metastatic muscle-invasive bladder cancer (MIBC). The assay, the Noninvasive Test…
Angela Hirbe, MD, PhD, discusses the potential significance of MET inhibitors such as mirdametinib for adult and pediatric patients with NF1-PN.
